Andera Partners

Summary

In 1953 was created Andera Partners, which is appeared as VC. The fund was located in Europe if to be more exact in France. The main department of described VC is located in the Paris.

We also calculated 28 valuable employees in our database.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Andera Partners, startups are often financed by Neomed Management, Omnes Capital, Ysios Capital. The meaningful sponsors for the fund in investment in the same round are Omnes Capital, Idinvest Partners, Gimv. In the next rounds fund is usually obtained by Neomed Management, VI Partners AG, Omnes Capital.

The real fund results show that this VC is 20 percentage points more often commits exit comparing to other companies. Comparing to the other companies, this Andera Partners performs on 0 percentage points more the average number of lead investments. The top amount of exits for fund were in 2015. The fund is constantly included in 7-12 investment rounds annually. The important activity for fund was in 2015. Despite it in 2019 the fund had an activity. The usual things for fund are deals in the range of 10 - 50 millions dollars.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - France. Among the various public portfolio startups of the fund, we may underline Vivoryon Therapeutics, AM Pharma, Arvelle Therapeutics The fund has specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. Among the most successful fund investment fields, there are Manufacturing, Health Diagnostics.